NDC 65162-596

Aspirin and Extended-Release Dipyridamole

Aspirin And Extended-release Dipyridamole

Aspirin and Extended-Release Dipyridamole is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Aspirin; Dipyridamole.

Product ID65162-596_1295f349-0855-486a-bbcc-c715f5ac99ec
NDC65162-596
Product TypeHuman Prescription Drug
Proprietary NameAspirin and Extended-Release Dipyridamole
Generic NameAspirin And Extended-release Dipyridamole
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2016-03-28
Marketing CategoryANDA / ANDA
Application NumberANDA206392
Labeler NameAmneal Pharmaceuticals LLC
Substance NameASPIRIN; DIPYRIDAMOLE
Active Ingredient Strength25 mg/1; mg/1
Pharm ClassesAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Platelet Aggregation Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65162-596-06

60 CAPSULE in 1 BOTTLE (65162-596-06)
Marketing Start Date2016-03-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65162-596-06 [65162059606]

Aspirin and Extended-Release Dipyridamole CAPSULE
Marketing CategoryANDA
Application NumberANDA206392
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-03-28

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN25 mg/1

OpenFDA Data

SPL SET ID:369cb8a3-e1e4-4150-859d-4f788436ddca
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 259081
  • Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • UPC Code
  • 0365162596069
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Decreased Platelet Aggregation [PE]
    • Platelet Aggregation Inhibitor [EPC]
    • Anti-Inflammatory Agents
    • Non-Steroidal [CS]

    Medicade Reported Pricing

    65162059606 ASPIRIN-DIPYRIDAM ER 25-200 MG

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Aspirin and Extended-Release Dipyridamole" or generic name "Aspirin And Extended-release Dipyridamole"

    NDCBrand NameGeneric Name
    42291-116Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    42571-274ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLEASPIRIN and Extended-Release DIPYRIDAMOLE
    51407-271Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    60687-305Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    62175-330Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    62559-850Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole
    65162-596Aspirin and Extended-Release DipyridamoleAspirin and Extended-Release Dipyridamole

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.